Clearstead Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $230K | Sell |
439
-112
| -20% | -$58.8K | ﹤0.01% | 846 |
|
|
2025
Q1 | $349K | Buy |
551
+41
| +8% | +$26K | 0.01% | 664 |
|
|
2024
Q4 | $363K | Buy |
510
+29
| +6% | +$20.7K | 0.01% | 662 |
|
|
2024
Q3 | $506K | Sell |
481
-23
| -5% | -$24.2K | 0.01% | 567 |
|
|
2024
Q2 | $530K | Buy |
504
+71
| +16% | +$74.6K | 0.01% | 525 |
|
|
2024
Q1 | $423K | Sell |
433
-46
| -10% | -$44.9K | 0.02% | 334 |
|
|
2023
Q4 | $421K | Sell |
479
-445
| -48% | -$391K | 0.02% | 337 |
|
|
2023
Q3 | $760K | Buy |
924
+445
| +93% | +$366K | 0.02% | 345 |
|
|
2023
Q2 | $344K | Buy |
479
+25
| +6% | +$18K | 0.02% | 345 |
|
|
2023
Q1 | $373K | Buy |
454
+128
| +39% | +$105K | 0.03% | 306 |
|
|
2022
Q4 | $235K | Buy |
326
+27
| +9% | +$19.5K | 0.02% | 358 |
|
|
2022
Q3 | $206K | Hold |
299
| – | – | 0.02% | 355 |
|
|
2022
Q2 | $177K | Hold |
299
| – | – | 0.01% | 393 |
|
|
2022
Q1 | $209K | Hold |
299
| – | – | 0.01% | 399 |
|
|
2021
Q4 | $189K | Buy |
299
+217
| +265% | +$137K | 0.01% | 404 |
|
|
2021
Q3 | $50K | Hold |
82
| – | – | ﹤0.01% | 610 |
|
|
2021
Q2 | $46K | Sell |
82
-22
| -21% | -$12.3K | ﹤0.01% | 573 |
|
|
2021
Q1 | $49K | Buy |
104
+35
| +51% | +$16.5K | ﹤0.01% | 548 |
|
|
2020
Q4 | $33K | Buy |
69
+2
| +3% | +$957 | ﹤0.01% | 567 |
|
|
2020
Q3 | $38K | Buy |
67
+15
| +29% | +$8.51K | ﹤0.01% | 504 |
|
|
2020
Q2 | $32K | Hold |
52
| – | – | ﹤0.01% | 478 |
|
|
2020
Q1 | $25K | Buy |
+52
| New | +$25K | ﹤0.01% | 483 |
|